文献速递放射性药物与辐射防护

肾小球滤过率的测定

Measurement of Glomerular Filtration Rate.
PubMed 文献 · Semin Nucl Med · 2022-01-19

肾小球滤过率(GFR)可由肌酐等内源性物质血浆浓度估算,但个体误差大,需要更准确结果时应直接测定。美国以外最常用51Cr-EDTA,近期供应减少后转向99mTc-DTPA,两者清除率差异小且与菊粉、碘海醇、碘他拉酸盐相当。血浆清除率技术较实用稳健,全血浆清除曲线面积法是参考方法但采血多,斜率截距法和单样本法更简便,在第三间隙扩大或GFR极低(<25 mL/min/1.73 m2)时需采用不同算法并采血至24小时;基于相机的方​​法因不精确目前不推荐。

要点

  • 需要更高准确性且结果影响治疗决策时,应测定GFR而非仅估算。
  • 51Cr-EDTA与99mTc-DTPA清除率差异小,均可用于GFR测定。
  • 第三间隙扩大或GFR<25 mL/min/1.73 m2时需用不同算法并采血至24小时。

核心结论

  • 需要更高准确性的临床情况应测定GFR,尤其当结果会影响治疗决策时。
  • 血浆清除率技术较尿液清除率更实用稳健,虽轻度高估GFR但精密度好。
  • 全血浆清除曲线面积法是参考方法,但因采血多主要用于研究环境。
  • 斜率截距法和单样本法更简便且准确,可用于大多数患者。
  • 基于相机的方法因不精确目前不推荐。

研究设计与样本

  • 本文为综述,未报告系统检索范围与样本量。

主要发现

  • 内源性物质估算GFR简单经济,但个体患者层面误差大。
  • 美国以外最常用51Cr-EDTA,近期供应减少后转向99mTc-DTPA,两者清除率差异小且与菊粉、碘海醇、碘他拉酸盐相当。
  • 尿液清除率是历史金标准,但因尿液收集困难及膀胱和肾脏引流系统残留活性测量不准确而易出错。
  • 第三间隙扩大或GFR<25 mL/min/1.73 m2的患者需采用不同算法并采血至24小时。
  • GFR生物学变异明显且易受测量误差影响,重复测量变异系数高,系列测定需变化>20%才视为显著。

关键数值与推荐

  • GFR<25 mL/min/1.73 m2或第三间隙扩大时,需采用不同计算方​​法并采血至24小时。
  • 系列测量中变化>20%才可视为显著。
  • 成人及儿童有可靠参考数据,多源自51Cr-EDTA清除率测量,也适用于99mTc-DTPA GFR。

临床怎么用

  • 需要更高准确性且结果影响治疗决策时,应测定GFR。
  • 大多数患者可采用斜率截距法或单样本法。
  • 第三间隙扩大或GFR<25 mL/min/1.73 m2时,需用不同算法并采血至24小时。
  • 系列测量需变化>20%才视为显著。
  • 基于相机的方法因不精确目前不推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Glomerular filtration rate (GFR) can be estimated from the plasma concentration of endogenous substances such as creatinine, and it is simple and cost-effective to do so, but the error on these estimates on an individual patient basis is high. Thus, GFR measurement is indicated in any clinical situation in which greater accuracy is required especially if the result will impact treatment decisions. Outside of the United States the radiopharmaceutical that has been most commonly used for measurement of GFR is 51Cr-EDTA. However, due to a recent reduction in supply, there has been a shift to 99mTc-DTPA. The differences in clearance between these two tracers are small, and their clearance is comparable to the non-radiopharmaceutical markers inulin, iohexol and iothalamate. A few PET GFR tracers are currently under investigation for clinical use. Measurement of the urinary clearance of a tracer is the historical gold standard technique, however this method is prone to error due to difficulties with urine collection and inaccuracies associated with measuring residual activity in the bladder and renal drainage systems. Plasma clearance techniques provide a more practical and robust alternative and have good precision despite overestimating GFR slightly. Measurement of the area under the full plasma clearance curve is the reference method but due to the large number of blood samples required, it is largely limited to research settings. The slope-intercept and single-sample methods are simpler yet accurate alternatives that can be used in most patients. However, in patients with expanded third spaces or very low GFR (<25 mL/min/1.73 m2), different calculation methods are used that require blood sampling up to 24 hours. Camera-based methods are currently not recommended due to their imprecision. For the purposes of interpreting a GFR result, reliable reference data is available for adults and children, mostly derived from 51Cr-EDTA clearance measurements, but applicable to 99mTc-DTPA GFR. GFR has notable biological variation and is susceptible to measurement errors, the combination of which translates into a high coefficient of variation for repeat measurements. Consequently, when serial measurements are performed, large changes (>20%) are required before a change can be regarded as significant. While biological variation is largely fixed, measurement errors can be minimized through careful work in combination with a system of thorough quality control checks.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Warwick J, Holness J. Measurement of Glomerular Filtration Rate. Semin Nucl Med. 2022. PMID: 35063168. doi:10.1053/j.semnuclmed.2021.12.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。